127 related articles for article (PubMed ID: 2895830)
21. Human immunodeficiency virus (HIV) type-1 GP120-specific cell-mediated cytotoxicity (CMC) and natural killer (NK) activity in HIV-infected (HIV+) subjects: enhancement with interleukin-2(IL-2), IL-12, and IL-15.
Lin SJ; Roberts RL; Ank BJ; Nguyen QH; Thomas EK; Stiehm ER
Clin Immunol Immunopathol; 1997 Feb; 82(2):163-73. PubMed ID: 9000485
[TBL] [Abstract][Full Text] [Related]
22. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor.
Lasky LA; Nakamura G; Smith DH; Fennie C; Shimasaki C; Patzer E; Berman P; Gregory T; Capon DJ
Cell; 1987 Sep; 50(6):975-85. PubMed ID: 2441877
[TBL] [Abstract][Full Text] [Related]
23. Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization.
Ho DD; Kaplan JC; Rackauskas IE; Gurney ME
Science; 1988 Feb; 239(4843):1021-3. PubMed ID: 2830667
[TBL] [Abstract][Full Text] [Related]
24. Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men.
Krohn K; Robey WG; Putney S; Arthur L; Nara P; Fischinger P; Gallo RC; Wong-Staal F; Ranki A
Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4994-8. PubMed ID: 2440037
[TBL] [Abstract][Full Text] [Related]
25. Recombinant HIV structural proteins detect specific cellular immunity in vitro in infected individuals.
Torseth JW; Berman PW; Merigan TC
AIDS Res Hum Retroviruses; 1988 Feb; 4(1):23-30. PubMed ID: 2835070
[TBL] [Abstract][Full Text] [Related]
26. Human monoclonal antibody against glycoproteins of human immunodeficiency virus.
Sugano T; Masuho Y; Matsumoto Y; Lake D; Gschwind C; Petersen EA; Hersh EM
Biochem Biophys Res Commun; 1988 Sep; 155(3):1105-12. PubMed ID: 2845963
[TBL] [Abstract][Full Text] [Related]
27. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus.
Montelaro RC; Robey WG; West MD; Issel CJ; Fischinger PJ
J Gen Virol; 1988 Jul; 69 ( Pt 7)():1711-7. PubMed ID: 2839603
[TBL] [Abstract][Full Text] [Related]
29. Human immunodeficiency virus gp120 glycoprotein detected by a monoclonal antibody to a synthetic peptide.
Chanh TC; Kennedy RC; Alderete BE; Kanda P; Eichberg JW; Dreesman GR
Eur J Immunol; 1986 Nov; 16(11):1465-8. PubMed ID: 3023102
[TBL] [Abstract][Full Text] [Related]
30. Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody.
Robey WG; Arthur LO; Matthews TJ; Langlois A; Copeland TD; Lerche NW; Oroszlan S; Bolognesi DP; Gilden RV; Fischinger PJ
Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7023-7. PubMed ID: 3018753
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
32. Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus.
Schneider J; Kaaden O; Copeland TD; Oroszlan S; Hunsmann G
J Gen Virol; 1986 Nov; 67 ( Pt 11)():2533-8. PubMed ID: 2431105
[TBL] [Abstract][Full Text] [Related]
33. Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans.
Berzofsky JA; Bensussan A; Cease KB; Bourge JF; Cheynier R; Lurhuma Z; Salaün JJ; Gallo RC; Shearer GM; Zagury D
Nature; 1988 Aug; 334(6184):706-8. PubMed ID: 2457809
[TBL] [Abstract][Full Text] [Related]
34. Cytokine augmentation of human immunodeficiency virus type 1 (HIV-1) gp120-specific cellular cytotoxicity.
Stine KC; Bolognesi D; Weinhold KJ
J Biol Response Mod; 1989 Oct; 8(5):501-10. PubMed ID: 2552026
[TBL] [Abstract][Full Text] [Related]
35. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
Ahmad A; Ladha A; Cohen EA; Menezes J
Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus type 1 glycoprotein 120-specific T lymphocytes provide intermolecular help for anti-CD4 autoantibody production in exposed uninfected subjects.
Furci L; Beretta A; Siccardi A; Lazzarin A; Confetti C; Magnani Z; Scarpellini P; Lopalco L; Burastero SE
AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1461-9. PubMed ID: 9390745
[TBL] [Abstract][Full Text] [Related]
37. Viral envelope protein of HTLV-III is the major target antigen for antibodies in hemophiliac patients.
Kitchen L; Malone G; Orgad S; Barin F; Zaizov R; Ramot B; Gazit E; Kreiss J; Leal M; Wichmann I
J Infect Dis; 1986 Apr; 153(4):788-90. PubMed ID: 3005438
[No Abstract] [Full Text] [Related]
38. Detection of HIV antigen and specific antibodies to HIV core and envelope proteins in sera of patients with HIV infection.
Cao YZ; Valentine F; Hojvat S; Allain JP; Rubinstein P; Mirabile M; Czelusniak S; Leuther M; Baker L; Friedman-Kien AE
Blood; 1987 Aug; 70(2):575-8. PubMed ID: 2886162
[TBL] [Abstract][Full Text] [Related]
39. A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells.
Chamow SM; Zhang D; Tan XY; Mhatre SM; Marsters SA; Peers DH; Byrn RA; Ashkenazi A; Junghans RP
J Hematother; 1995 Oct; 4(5):439-46. PubMed ID: 8581382
[TBL] [Abstract][Full Text] [Related]
40. Fusion of human B cell lines with HIV-1 envelope-expressing T cells is enhanced by antigen-specific Ig receptors. Possible mechanism for elimination of gp120-specific B cells in vivo.
Golding H; Dimitrov DS; Blackburn R; Manischewitz J; Blumenthal R; Golding B
J Immunol; 1993 Mar; 150(6):2506-16. PubMed ID: 7680694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
